Autoantibodies to dsDNA, Ro/SSA, and La/SSB in systemic lupus erythematosus

Advances in Clinical Chemistry

Volumn 37, Issue , 2003, Pages 129-172

  Chien, Jien Wen ^a   Lin, Ching Yuang ^a,b  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; DNA; RIBONUCLEOPROTEIN; SMALL CYTOPLASMIC RNA; SS A ANTIGEN; SS B ANTIGEN; SS-A ANTIGEN; SS-B ANTIGEN; SSA2 PROTEIN, HUMAN;

ANIMAL; CHEMISTRY; HUMAN; IMMUNOLOGY; PATHOPHYSIOLOGY; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; DNA; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; RIBONUCLEOPROTEINS; RNA, SMALL CYTOPLASMIC;

EID: 0037487156     PISSN: 00652423     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0065-2423(03)37008-8     Document Type: Article

References (353)

1. 1. Aarden L.A. de Groot E.R. Feltkamp T.E.W. Immunology of DNA. III. Crithidia luciliae , a simple substrate for the determination of anti-dsDNA with the immunofluorescence technique Ann. N. Y. Acad. Sci. 254 1975 505 515
2. 2. Abu-Shakra M. Urowitz M.B. Gladman D.D. Gough J. Mortality studies in systemic lupus erythematosus: Results from a single center. I. Causes of death J. Rheumatol. 22 1995 1259 1264
3. 3. Abu-Shakra M. Urowitz M.B. Gladman D.D. Gough J. Mortality studies in systemic lupus erythematosus: Results from a single center. II. Predictor variables for mortality J. Rheumatol. 22 1995 1265 1270
4. 4. Adams E. Basten A. Goodnow C.C. Intrinsic B cell hyporesponsiveness accounts for self-tolerance in lysozyme/anti-lysozyme double-transgenic mice Proc. Natl. Acad. Sci. USA 87 1990 5687 5691
5. 5. Akbar A.N. Lord J.M. Salmon M. IFN-alpha and IFN-beta: A link between immune memory and chronic inflammation Immunol. Today 21 2000 337 342
6. 6. Alarcon-Segovia D. Llorente L. Antibody penetration into living cells. IV. Different effects of anti-native DNA and anti-ribonucleoprotein IgG on the cell cycle of activated T gamma cells Clin. Exp. Immunol. 52 1983 365 371
7. 7. Alarcón-Segovia D. Llorente L. Fishbein E. Díaz-Jouanen E. Abnormalities in the content of nucleic acids of peripheral blood mononuclear cells from patients with systemic lupus erythematosus Arthritis Rheum. 25 1982 304 317
8. 8. Alarcón-Segovia D. Ruiz-Argüelles A. Fishbein E. Antibody to nuclear ribonucleoprotein penetrates live human mononuclear cells through Fc receptors Nature 271 1978 67 69
9. 9. Alarcón-Segovia D. Ruiz-Argüelles A. Llorente L. Antibody penetration into living cells. II. Anti-ribonucleoprotein IgG penetrates into Tgamma lymphocytes causing their deletion and the abrogation of suppressor function J. Immunol. 122 1979 1855 1862
10. 10. Alarcon-Segovia D. Ruiz-Arguelles A. Llorente L. Broken dogma: Penetration of autoantibodies into living cells Immunol. Today 17 1996 163 164
11. 11. Alberdi F. Dadone J. Ryazanov A. Isenberg D.A. Ravirajan C. Reichlin M. Crossreaction of lupus anti-dsDNA antibodies with protein translation factor EF-2 Trends Biochem. Sci. 15 1990 420 424
12. 12. Albert M.L. Sauter B. Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs Nature 392 1998 86 89
13. 13. Alexander E.L. Buyon J.P. Lane J. Lafond-Walker A. Provost T.T. Guarnieri T. Anti-SS-A/Ro SS-B/La antibodies bind to neonatal rabbit cardiac cells and preferentially inhibit in vitro cardiac repolarization J. Autoimmun. 2 1989 463 469
14. 14. Alexander E. Buyon J.P. Provost T.T. Guarnieri T. Anti-Ro/SS-A antibodies in the pathophysiology of congenital heart block in neonatal lupus syndrome, an experimental model. In vitro evectrophysiologic and immunocytochemical studies Arthritis Rheum. 35 1992 176 189
15. 15. Alspaugh M.A. Maddison P. Resolution of the identity of certain antigen-antibody systems in systemic lupus erythematosus and Sjögren's syndrome: An interlaboratory collaboration Arthritis Rheum. 22 1979 796 798
16. 16. Alspaugh M.A. Tan E.M. Antibodies to cellular antigens in Sjögren's syndrome J. Clin. Invest. 55 1975 1067 1073
17. 17. Alyward R.D. Congenital heart block Br. Med. J. 1 1928 943
18. 18. Amoura Z. Chabre H. Koutouzov S. Lotton C. Cabrespines A. Nucleosomerestricted antibodies are detected before anti-dsDNA and/or antihistone antibodies in serum of MRL-Mp lpr/lpr and +/+ mice, and are present in kidney eluates of lupus mice with proteinuria Arthritis Rheum. 37 1994 1684 1688
19. 19. Amoura Z. Piette J.-C. Chabre H. Cacoub P. Papo T. Circulating plasma levels of nucleosomes in patients with systemic lupus erythematosus: Correlation with serum antinucleosome antibody titers and absence of clear association with disease activity Arthritis Rheum. 40 1997 2217 2225
20. 20. Andreassen K. Bredholt G. Moens U. Bendiksen S. Kauric G. Rekvig O.P. T cell lines specific for polyomavirus T-antigen recognize T-antigen complexed with nucleosomes: A molecular basis for anti-DNA antibody production Eur. J. Immunol. 29 1999 2715 2728
21. 21. Andrews B.S. Eisenberg R.A. Theofilopoulos A.N. Izui S. Wilson C.B. Spontaneous murine lupus-like syndromes: Clinical and immunopathological manifestations in several strains J. Exp. Med. 148 1978 1198 1215
22. 22. Anne-Barbara M. Evelyn V.H. The role of environment in systemic lupus erythematosus and associated disorders D.J. Wallace B.H. Hahn Dubois' Lupus Erythematosus 1997 Williams & Wilkins Baltimore 31 47
23. 23. Appel A.E. Sablay L.B. Golden R.A. Barland P. Grayzel A.I. Bank N. The effect of normalization of serum complement and anti-DNA antibody on the course of lupus nephritis Am. J. Med. 64 1978 274 283
24. 1. Bachmann M. Falke D. Schroder H.C. Muller W.E. Intracellular distribution of the La antigen in CV-1 cells after herpes simplex virus type 1 infection compared with the localization of U small nuclear ribonucleoprotein particles J. Gen. Virol. 70 1989 881 891
25. 2. Bachmann M. Pfeifer K. Schroder H.C. Muller W.E. The La antigen shuttles between the nucleus and the cytoplasm in CV-1 cells Mol. Cell. Biochem. 85 1989 103 114
26. 3. Barry M.M. Mol C.D. Anderson W.F. Lee J.S. Sequencing and modeling of anti-DNA immunoglobulin Fv domains. Comparison with crystal structures J. Biol. Chem. 269 1994 3623 3632
27. 4. Banchereau J. Steinman R.M. Dendritic cells and the control of immunity Nature 392 1998 245 252
28. 5. Bankhurst A.D. Interferons and systemic lupus erythematosus J. Rheumatol. 13 1987 63 67
29. 6. Bell D.A. Maddison P.J. Serologic subsets in systemic lupus erythematosus: An examination of autoantibodies in relationship to clinical features of disease and HLA antigens Arthritis Rheum. 23 1980 1268 1273
30. 7. Bell E.B. Shand F.L. Changes in lymphocyte recirculation and liberation of the adoptive memory response from cellular regulation in irradiated recipients Eur. J. Immunol. 5 1975 1 7
31. 8. Bell S.E. Goodnow C.C. A selective defect in IgM antigen receptor synthesis and transport causes loss of cell surface IgM expression on tolerant B lymphocytes EMBO J. 13 1994 816 826
32. 9. Ben-Chetrit E. Fox R.I. Tan E.M. Dissociation of immune responses to the SS-A (Ro) 52-kd and 60-kd polypeptides in systemic lupus erythematosus and Sjögren's syndrome Arthritis Rheum. 33 1990 349 355
33. 10. Benedek G.B. Historical background of discoid and systemic lupus erythematosus D.J. Wallace B.H. Hahn Dubois' Lupus Erythematosus 1997 Williams & Wilkins Baltimore 3 16
34. 11. Bengtsson A.A. Sturfelt G. Truedsson L. Blomberg J. Alm G. Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies Lupus 9 2000 664 671
35. 12. Bennett R.M. Cornell K.A. Merritt M.J. Bakke A.C. Hsu P.H. Hefeneider S.H. Autoimmunity to a 28–30 kD cell membrane DNA binding protein: Occurrence in selected sera from patients with SLE and mixed connective tissue disease (MCTD) Clin. Exp. Immunol. 86 1991 374 379
36. 13. Bennett R.M. Gabor G.T. Merritt M.M. DNA binding to human leukocytes. Evidence for a receptor-mediated association, internalization, and degradation of DNA J. Clin. Invest. 76 1985 2182 2190
37. 14. Bernstein K.A. Valerio R.D. Lefkowith J.B. Glomerular binding activity in MRL lpr serum consists of antibodies that bind to a DNA/histone/type IV collagen complex J. Immunol. 154 1995 2424 2433
38. 15. Bias W.B. Reveille J.D. Beaty T.L.H. Meyers D.A. Arnett F.C. Evidence that autoimmunity in man is a Mendelian dominant trait Am. J. Hum. Genet. 39 1986 584 602
39. 16. Bickerstaff M.C. Hutchinson W.L. Herbert J. Tennent G.A. Bybee A. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity Nat. Med. 5 1999 694 697
40. 17. Blomberg J. Nived O. Pipkorn R. Bengtsson A. Erlinge D. Sturfelt G. Increased antiretroviral antibody reactivity in sera from a defined population of patients with systemic lupus erythematosus. Correlation with autoantibodies and clinical manifestations Arthritis Rheum. 37 1994 57 66
41. 18. Boey M.L. Peebles C.L. Tsay G. Feng P.H. Tan E.M. Clinical and autoantibody correlations in Orientals with systemic lupus erythematosus Ann. Rheum. Dis. 47 1988 918 923
42. 19. Bogdan C. The function of type I interferons in antimicrobial immunity Curr. Opin. Immunol. 12 2000 419 424
43. 20. Boire G. Ménard H.A. Gendron M. Lussier A. Myhal D. Rheumatoid arthritis: Anti-Ro antibodies define a non-HLA-DR4 associated clinicoserological cluster J. Rheumatol. 20 1993 1654 1660
44. 21. Boletis J.N. Ioannidis J.P. Boki K.A. Moutsopoulos H.M. Intravenous immunoglobulin compared with cyclophosphamide for proliferative lupus nephritis Lancet 354 1999 569 570
45. 22. Boutjdir M. Chen L. Zhang Z.H. Tseng C.E. DiDonato F. Arrhythmogenicity of IgG and anti-52-kD SSA/Ro affinity-purified antibodies from mothers of children with congenital heart block Circ. Res. 80 1997 354 362
46. 23. Bozic B. Pruijn G.J. Rozman B. van Venrooij W.J. Sera from patients with rheumatic diseases recognize different epitope regions on the 52-kD Ro/SS-A protein Clin. Exp. Immunol. 94 1993 227 235
47. 24. Brandt L. Hedberg H. Impaired phagocytosis by peripheral blood granulocytes in systemic lupus erythematosus Scand. J. Haematol. 6 1969 348 353
48. 25. Brinkman K. Termaat R. van den Brink H. Berden J.H. Smeenk R.J. The specificity of the anti-dsDNA ELISA. A closer look J. Immunol. Meth. 139 1991 91 100
49. 26. Bruneau C. Benveniste J. Circulating DNA:anti-DNA complexes in systemic lupus erythematosus: Detection and characterization by ultracentrifugation J. Clin. Invest. 64 1979 191 198
50. 27. Burlingame R.W. Boey M.L. Starkebaum G. Rubin R.L. The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus J. Clin. Invest. 94 1994 184 192
51. 28. Burlingame R.W. Rubin R.L. Subnucleosome structures as substrates in enzyme-linked immunosorbent assays J. Immunol. Meth. 134 1990 187 199
52. 29. Burlingame R.W. Rubin R.L. Balderas R.S. Theofilopoulos A.N. Genesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen J. Clin. Invest. 91 1993 1687 1696
53. 30. Burns J. Rosenzweig A. Zweiman B. Lisak R.P. Isolation of myelin basic proteinreactive T cell lines from normal human blood Cell. Immunol. 81 1993 435 440
54. 31. Buskila D. Shoenfeld Y. Anti-DNA antibodies R.G. Lahita Systemic Lupus Erythematosus 1992 Churchill Livingstone New York 205 236
55. 32. Buyon J.P. Neonatal lupus syndromes Curr. Opin. Rheum. 6 1994 523 529
56. 33. Buyon J.P. Hiebert R. Copel J. Craft J. Friedman D. Autoimmune-associated congenital heart block: Demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry J. Am. Coll. Cardiol. 31 1998 1658 1666
57. 34. Buyon J.P. Slade S.G. Reveille J.D. Hamel J.C. Chan E.K. Autoantibody responses to the “native” 52-kDa SS-A/Ro protein in neonatal lupus syndromes, systemic lupus erythematosus, and Sjogren's syndrome J. Immunol. 152 1994 3675 3684
58. 35. Buyon J.P. Winchester R. Congenital complete heart block. A human model of passively acquired autoimmune injury Arthritis Rheum. 33 1990 609 614
59. 36. Buyon J.P. Winchester R.J. Slade S.G. Arnett F. Copel J. Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children. Comparison of enzyme-linked immunosorbent assay and immunoblot for measurement of anti-SS-A/Ro and anti-SS-B/La antibodies Arthritis Rheum. 36 1993 1263 1273
60. 1. Carroll M.C. A protective role for innate immunity in autoimmune disease Clin. Immunol. 95 2000 S30 S38
61. 2. Carroll P. Stafford D. Schwartz R.S. Stollar B.D. Murine monoclonal anti-DNA autoantibodies bind to endogenous bacteria J. Immunol. 135 1985 1086 1090
62. 3. Casciola-Rosen L.A. Anhalt G. Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes J. Exp. Med. 179 1994 1317 1330
63. 4. Casciola-Rosen L. Rosen A. Ultraviolet light-induced keratinocyte apoptosis: A potential mechanism for the induction of skin lesions and autoantibody production in LE Lupus 6 1997 175 180
64. 5. Casiano C.A. Martin S.J. Green D.R. Tan E.M. Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1)-mediated T cell apoptosis J. Exp. Med. 184 1996 765 770
65. 6. Cederblad B. Blömberg S. Vallin H. Perers A. Alm G.V. Rönnblom L. Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-alpha-producing cells J. Autoimmun. 11 1998 465 470
66. 7. Ceppellini R. Polli E. Celada F. A DNA-reacting factor in serum of a patient with lupus erythematosus diffuses Proc. Soc. Exp. Biol. Med. 96 1957 572 574
67. 8. Cervera R. Khamashta M.A. Font J. Sebastiani G.D. Gil A. Systemic lupus erythematosus: Clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus Medicine 72 1993 113 124
68. 9. Chabre H. Amoura Z. Piette J.-C. Godeau P. Abch J.-F. Koutouzov S. Presence of nucleosome-restricted antibodies in patients with systemic lupus erythematosus Arthritis Rheum. 38 1995 1485 1491
69. 10. Chambers J.C. Denan D. Martin B.J. Keene J.D. Genomic structure and amino acid sequence domains of the human La autoantigen J. Biol. Chem. 34 1988 18043 18051
70. 11. Chambers J.C. Keene J.D. Isolation and analysis of cDNA clones expressing human lupus La antigen Proc. Natl. Acad. Sci. USA 82 1985 2115 2119
71. 12. Chan E.K. Di Donato F. Hamel J.C. Tseng C.E. Buyon J.P. 52-kD SS-A/Ro: Genomic structure and identification of an alternatively spliced transcript encoding a novel leucine zipper-minus autoantigen expressed in fetal and adult heart J. Exp. Med. 182 1995 983 992
72. 13. Chan T.M. Li F.K. Tang C.S. Wong R.W. Fang G.X. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis N. Engl. J. Med. 343 2000 1156 1162
73. 14. Chan E.K. Sullivan K.F. Tan E.M. Ribonucleoprotein SS-B/La belongs to a protein family with consensus sequences for RNA-binding Nucleic Acids Res. 17 1989 2233 2244
74. 15. Chang B. Casali P. The CDR1 sequences of a major proportion of human germline Ig VH genes are inherently susceptible to amino acid replacement Immunol. Today 15 1994 367 373
75. 16. Charles L.A. Falk R.J. Jennette J.C. Reactivity of anti-neutrophil cytoplasmic autoantibodies with HL-60 cells Clin. Immunol. Immunopathol. 53 1989 243 253
76. 17. Chien J.W. Lin C.Y. Yang L.Y. Correlation between anti-Ro/La titers and clinical Chung Hua Hsueh Tsa Chih Chin. Med. J. 64 2001 283 291
77. 18. Chien Y.H. Gascoigne N.R. Kavler J. Lee N.E. Davis M.M. Somatic recombination in a murine T-cell receptor gene Nature 309 1984 322 326
78. 19. Clark M.R. Liu L. Clarkson S.B. Ory P.A. Goldstein I.M. An abnormality of the gene that encodes neutrophil Fc receptor III in a patient with systemic lupus erythematosus J. Clin. Invest. 86 1990 341 346
79. 20. Clark G. Reichlin M. Tomasi T.B.J. Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythematosus J. Immunol. 102 1969 117 122
80. 21. Cohen A.S. Reynolds W.E. Franklin E.C. Kulka J.P. Ropes M.W. Preliminary criteria for the classification of systemic lupus erythematosus Bull. Rheum. Dis. 21 1971 643 648
81. 1. Davies K.A. Complement, immune complexes and systemic lupus erythematosus Br. J. Rheum. 35 1996 5 23
82. 2. Davis M.M. Bjorkman P.J. T-cell antigen receptor genes and T-cell recognition Nature 334 1988 395 402
83. 3. Davis J.C.J. Manzi S. Yarboro C. Rairie J. Mcinnes I. Recombinant human DNase I (rhDNase) in patients with lupus nephritis Lupus 8 1999 68 76
84. 4. Davis P. Percy J.S. Russell A.S. Correlation between levels of DNA antibodies and clinical disease activity in systemic lupus erythematosus Ann. Rheum. Dis. 36 1977 157 159
85. 5. Demaison C. Chastagner P. Theze J. Zouali M. Somatic diversification in the heavy chain variable region genes expressed by human autoantibodies bearing a lupus-associated nephritogenic anti-DNA idiotype Proc. Natl. Acad. Sci. USA 91 1994 514 518
86. 6. Deng J.-S. Sontheimer R.D. Lipscomb M.F. Gilliam J.N. The binding of antihistone antibodies to Crithidia luciliae kinetoplasts is growth cycle-dependent Arthritis Rheum. 28 1985 163 168
87. 7. Desai D.D. Krishnan M.R. Swindle J.T. Marion T.N. Antigen specific induction of antibodies against native mammalian DNA in nonautoimmune mice J. Immunol. 151 1993 1614 1626
88. 8. (G. Ryan and H. Ripperger, transl.) de Voragine J. The Golden Legend 1969 Arno Press New York
89. 9. Diamond B. Katz J.B. Paul E. Aranow C. Lustgarten D. Scharff M.D. The role of somatic mutation in the pathogenic anti-DNA response Ann. Rev. Immunol. 10 1992 731 757
90. 10. Dickerson P.A. Prendiville J.S. Thrombocytopenia and hepatosplenomegaly in a newborn Pediatr. Dermatol. 6 1989 346 348
91. 11. Dörner T. Chaoui R. Feist E. Goldner B. Yamamoto K. Hiepe F. Significantly increased maternal and fetal IgG autoantibody levels to 52 kD Ro(SS-A) and La(SS-B) in complete congenital heart block J. Autoimmun. 8 1995 675 684
92. 12. Dörner T. Feist E. Held C. Conrad K. Burmester G.R. Hiepe F. Differential recognition of the 52-kd Ro(SS-A) antigen by sera from patients with primary biliary cirrhosis and primary Sjogren's syndrome Hepatology 24 1996 1404 1407
93. 13. Dörner T. Feist E. Pruss A. Chaoui R. Göldner B. Hiepe F. Significance of autoantibodies in neonatal lupus erythematosus Int. Arch. Allergy immunol. 123 2000 58 66
94. 14. Dörner T. Feist E. Wegenmann A. Kato T. Yamamoto K. Anti-52 kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen J. Rheum. 23 1996 462 468
95. 15. Dörner T. Hiepe F. Göldner B. Apostoloff E. Investigations into Ro-specific antibody-associated congenital cardiac conduction defects Clin. Invest. 70 1992 492 496
96. 16. Dörner T. Trebeljahr G. Göldner B. Yamamoto K. Apostoloff E. Hiepe F. Detection of autoantibodies to Ro(SS-A), La(SS-B) and U1RNP in different congenital heart rhythm disorders using immunoblot and enzyme immunoassay J. Autoimmun. 7 1994 93 106
97. 17. Dugan E.M. Tunnessen W.W. Honig P.J. Watson R.M. U1RNP antibody-positive neonatal lupus. A report of two cases with immunogenetic studies Arch. Dermatol. 128 1992 1490 1494
98. 1. Ebling F. Hahn B.H. Restricted subpopulations of DNA antibodies in kidneys of mice with systemic lupus: Comparison of antibodies in serum and renal eluates Arthritis Rheum. 23 1980 392 403
99. 2. Ebling F.M. Hahn B.H. Pathogenic subsets of antibodies to DNA Int. Rev. Immunol. 5 1989 79 95
100. 3. Ehrenstein M.R. Katz D.R. Griffiths M.H. Papadaki L. Winkler T.H. Human IgG anti-DNA antibodies deposit in kidneys and induce proteinuria in SCID mice Kidney Int. 48 1995 705 711
101. 4. Eilat D. Fischel R. Recurrent utilization of genetic elements in V regions of antinucleic acid antibodies from autoimmune mice J. Immunol. 147 1991 361 368
102. 5. Emlen W. Mannik M. Clearance of circulating DNA-anti-DNA immune complexes in mice J. Exp. Med. 155 1982 1210 1215
103. 6. Emlen W. Niebur J. Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus J. Immunol. 152 1994 3685 3692
104. 7. Enenkel B. Jung D. Frey J. Molecular basis of IgG Fc receptor III defect in a patient with systemic lupus erythematosus Eur. J. Immunol. 21 1992 659 663
105. 8. Engvall E. Determination of antibodies to DNA by ELISA Lancet 2 1976 1410
106. 9. Eskdale J. Wordsworth P. Bowman S. Field M. Gallagher G. Association between polymorphisms at the human Il-10 locus and systemic lupus erythematosus Tissue Antigen 49 1997 635 639
107. 10. Esterly N.B. Neonatal lupus erythematosus Pediatr. Dermatol. 3 1986 417 424
108. 1. Faaber P. Rijke T.P.M. van de Putte L.B.A. Capel P.J.A. Berden J.H.M. Cross-reactivity of human and murine anti-DNA antibodies with heparin sulfate J. Clin. Invest. 77 1986 1824 1830
109. 2. Fadok V.A. Bratton D.L. Konowal A. Freed P.W. Westcott J.Y. Henson P.M. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF J. Clin. Invest. 101 1998 890 898
110. 3. Ferguson P.J. Reist C.J. Martin E.N. Johnson C. Greene K.L. Antigen-based heteropolymers. A potential therapy for binding and clearing autoantibodies via erythrocyte CR1 Arthritis Rheum. 38 1995 190 200
111. 4. Fielder A.H.L. Walport M.J. Batchelor J.R. Rynes R.I. Black C.M. Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: Importance of null alleles of C4A and C4B in determining disease susceptibility Br. Med. J. 286 1983 425 428
112. 5. Foster M.H. Cizman B. Madaio M.P. Nephritogenic autoantibodies in systemic lupus erythematosus. Immunochemical properties, mechanisms of immune deposition, and genetic origins Lab. Invest. 69 1993 494 507
113. 6. Foster M.H. Kieber-Emmons T. Ohliger M. Madaio M.P. Molecular and structural analysis of nuclear localizing anti-DNA lupus antibodies Immunol. Res. 13 1994 186 206
114. 7. Foster M.H. Cizman B. Madaio M.P. Biology of disease. Nephritogenic autoantibodies in systemic lupus erythematosus: Immunochemical properties, mechanisms of immune deposition, and genetic origins Lab. Invest. 69 1993 494 507
115. 8. Fournie G.J. Detection of nucleosome-IgG immune complexes in ascites from mice transplanted with anti-DNA antibody-secreting hybridomas and in plasma form MRL-lpr/lpr mice Clin. Exp. Immunol. 104 1996 236 240
116. 9. Franek F. Dolnikova J. Nucleosomes occurring in protein-free hybridoma cell culture: Evidence for programmed cell death FEBS Lett. 284 1991 285 287
117. 10. Frank M.B. Itoh K. McCubbin V. Epitope mapping of the 52-kD Ro/SSA autoantigen Clin. Exp. Immunol. 95 1994 390 396
118. 11. Freitas A.A. Rosado B.A. Lymphocyte life span: Homeostasis, selection and competition Immunol. Today 14 1993 25 29
119. 12. Freitas A.A. Rosado M.M. Viale A.C. Grandieu A. The role of cellular competition in B cell survival and selection of B cell repertoires Eur. J. Immunol. 25 1995 1729 1738
120. 13. Friou G.J. Finch S.C. Detre K.D. Interaction of nuclei and globulin from lupus erythematosus serum demonstrated with fluorescent antibody J. Immunol. 80 1958 324 329
121. 14. Fulcher D.A. Lyons A.B. Korn S.L. Cook M.C. Koleda C. The fate of self-reactive B-cells depends primarily on the degree of antigen receptor engagement and availability of T-cell help J. Exp. Med. 83 1996 2313 2328
122. 15. Fulcher D.A. Basten A. Reduced life span of anergic self-reactive B cells in a transgenic mouse model J. Exp. Med. 179 1994 125 134
123. 1. Gaffney P. Kearns G.M. Shark K.B. Ortmann W.A. Selby S.A. A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families Proc. Natl. Acad. Sci. USA 95 1998 14875 14879
124. 2. Gallucci S. Lolkema M. Matzinger P. Natural adjuvants: Endogenous activators of dendritic cells Nat. Med. 5 1999 1249 1255
125. 3. Garcia S. Nascimento J.H. Bonfa E. Levy R. Oliveira S.F. Cellular mechanism of the conduction abnormalities induced by serum from anti-Ro/SSA-positive patients in rabbit hearts J. Clin. Invest. 93 1994 718 724
126. 4. Garcia-de la Torre I. Sanchez-Gurrero A. Salmon-de la Torre G. Hernandez-Vazquez L. Prevalence of anti-SSA (Ro) antibodies in a Mexican population of patients with various systemic rheumatic diseases J. Rheumatol. 14 1987 179 181
127. 5. Gay S. Losman M.J. Koopman W.J. Miller E.J. Interaction of DNA with connective tissue matrix proteins reveals preferential binding to type V collagen J. Immunol. 135 1985 1097 1100
128. 6. Gaynor B. Putterman C. Valadon P. Spatz L. Scharff M.D. Diamond B. Peptide inhibition of glomerular deposition of an anti-DNA antibody Proc. Natl. Acad. Sci. USA 94 1997 1955 1960
129. 7. Gilkeson G.S. Bernstein K.A. Pippin A.M.M. Clark S.H. Marion T. The influence of variable region somatic mutations on the specificity and pathogenicity of murine monoclonal anti-DNA antibodies Clin. Immunol. Immunopathol. 68 1993 283 292
130. 8. Gilkeson G.S. Ruiz P. Howell D. Lefkowith J.B. Pisetsky D.S. Induction of immunemediated glomerulonephritis in normal mice immunized with bacterial DNA Clin. Immunol. Immunopathol. 68 1993 283 292
131. 9. Golan T.D. Elkon K.B. Gharavi A.E. Krueger J.G. Enhanced membrane binding of autoantibodies to cultured keratinocytes of systemic lupus erythematosus patients after ultraviolet B/ultraviolet A irradiation J. Clin. Invest. 90 1992 1067 1076
132. 10. Gololobov G.V. Rumbley C.A. Rumbley J.N. Schourov D.V. Makarevich O.I. DNA hydrolysis by monoclonal anti-ssDNA autoantibody BV 04-01: Origins of catalytic activity Mol. Immunol. 34 1997 1083 1093
133. 11. Goodnow C.C. Crosbie J. Adelstein S. Lavoie T.B. Smith-Gill S.J. Altered immunoglobulin expression and function silencing of self-reactive B lymphocytes in transgenic mice Nature 334 1988 676 682
134. 12. Gottlieb E. Steitz J.A. The RNA binding protein La influences both the accuracy and the efficiency of RNA polymerase III transcription in vitro EMBO J. 8 1989 841 850
135. 13. Gottlieb E. Steitz J.A. Function of the mammalian La protein: Evidence for its action in transcription termination by RNA polymerase III EMBO J. 8 1989 851 861
136. 14. Gourley M.F. Austin H.A. Scott D. Yarboro C.H. Vaughan E.M. Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial Ann. Intern. Med. 125 1996 549 557
137. 15. Grumel F.C. Conkell A. Bodmer J.C. Bodmer W.F. McDevitt H.O. Histocompatibility (HL-A) antigens associated with systemic lupus erythematosus N. Engl. J. Med. 285 1971 193 196
138. 16. Guillermo R.I. Munther A.K. Gabriella C. Graham R.V.H. Systemic lupus erythematosus Lancet 357 2001 1027 1032
139. 17. Gupta R.C. Simpson W.A. Raghow R. Interaction of fibronectin with DNA/anti-DNA complexes from systemic lupus erythematosus: Role of activated complement Cl in modulation of the interactions Clin. Immunol. Immunopathol. 46 1988 368 381
140. 1. Hahn B.H. Tsao B.P. Autoantibodies to DNA D.J. Wallace B.H. Hahn “Dubois' Systemic Lupus Erythematosus” 1993 Lea & Febiger Philadelphia 195 201
141. 2. Han S. Zheng B. Dao Porto J. Kelsoe G. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl) acetyl IV-affinity-dependent, antigen driven B cell apoptosis in germinal centers as a mechanism for maintaining self-tolerance J. Exp. Med. 182 1995 1635 1644
142. 3. Harley J.B. Reichlin M. Antibodies to Ro/SSA and La/SSB D.J. Wallace B.H. Hahn “Dubois' Lupus Erythematosus” 1997 Williams & Wilkins Baltimore 443 455
143. 4. Hargraves M.M. Production in vitro of the LE cell phenomenon: Use of normal bone marrow elements and blood plasma from patients with acute disseminated lupus erythematosus Proc. Staff Mayo Clin. 24 1949 234 237
144. 5. Harley J.B. Sheldon P. Neas B. Murphy S. Wallace D.J. Systemic lupus erythematosus: Consideration for a genetic approach J. Invest. Dermatol. 103 1994 144S 149S
145. 6. Hartley S.B. Cooke M.P. Fulcher D. Harris A.W. Cory S. Elimination of selfreactive B lymphocytes proceeds in two stages: Arrested development and cell death Cell 72 1993 325 335
146. 7. Baltimore Hecht B. Siegel N. Adler M. Kashgarian M. Hayslett J.P. Prognostic indices in lupus nephritis Medicine 55 1976 163 181
147. 8. Herrmann M. Voll R.E. Zoller O.M. Hagenhofer M. Ponner B.B. Kalden J.R. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus Arthritis Rheum. 41 1998 1241 1250
148. 9. Herrmann M. Zoller O.M. Hagenhofer M. Voll R. Kalden J.R. What triggers antidsDNA antibodies? Mol. Biol. Rep. 23 1996 265 267
149. 10. Hess E.V. Lupus: The clinical entity G.M. Kammer G.C. Tsokos “Lupus: Molecular and Cellular Pathogenesis” 1999 Humana Press Totowa, NJ 1 12
150. 11. Hoch S. Schur P.H. Schwaber J. Frequency of anti-DNA antibody producing cells from normals and patients with systemic lupus erythematosus Clin. Immunol. Immunopathol. 24 1983 28 37
151. 12. Hochberg M.C. Updating the American College of Rheumatology Revised Criteria for classification of SLE Arthritis Rheum. 40 1997 1725
152. 13. Hochberg M. The epidemiology of systemic lupus erythematosus D.J. Wallace B.H. Hahn “Dubois' Lupus Erythematosus” 1997 Williams & Wilkins Baltimore 49 65
153. 14. Holborow J. Weir D.M. Johnson G.D. A serum factor in lupus erythematosus with affinity for tissue nuclei Br. Med. J. 2 1957 732 734
154. 15. Hooks J.J. Moutsopoulos H.M. Geis S.A. Stahl N.I. Decker J.L. Immune interferon in the circulation of patients with autoimmune disease N. Engl. J. Med. 301 1979 5 8
155. 16. Hurd E.R. Ziff M. Quantitative studies of immunoglobulin deposition in the kidney, glomerular cell proliferation and glomerulosclerosis in NZB/NZW F1 hybrid mice Clin. Exp. Immunol. 26 1976 261 268
156. 1. Ioannou Y. Isenberg D.A. Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy Arthritis Rheum. 43 2000 1431 1442
157. 2. Izui S. Lambert P.H. Mescher P.A. In vitro demonstration of a particular affinity of glomerular basement membrane and collagen for DNA: A possible basis for a local formation of DNA-anti-DNA complexes in systemic lupus erythematosus J. Exp. Med. 144 1976 428 443
158. 3. Izui S. Lambert P.H. Mescher P.A. Failure to detect circulating DNA-anti-DNA complexes by four radioimmunological methods in patients with systemic lupus erythematosus Clin. Exp. Immunol. 30 1977 384 392
159. 1. Jacob L. Lety M.A. Louvard D. Bach J.F. Binding of a monoclonal anti-DNA autoantibody to identical proteins(s) present at the surface of several human cell types involved in lupus pathogenesis J. Clin. Invest. 75 1985 315 317
160. 2. Jacob L. Viard J.P. Allenet B. Anin M.F. Slama F.B. A monoclonal anti-doublestranded DNA autoantibody binds to a 94-kDa cell-surface protein on various cell types via nucleosomes or a DNA-histone complex Proc. Natl. Acad. Sci. USA 86 1989 4669 4673
161. 3. John B.H. Kathy L.M. Patrick M.G. Timothy W.B. The genetics of human systemic lupus erythematosus Curr. Opin. Immunol. 10 1998 690 696
162. 4. Jonsson J. Norberg R. Effect of enzyme treatment of Crithidia luciliae on the reactivity of its kinetoplast with anti-DNA sera Scand. J. Rheumatol. 5 1976 221 226
163. 5. Julkunen H. Siren M.K. Kaaja R. Kurki P. Friman C. Koskimies S. Maternal HLA antigens and antibodies to SS-A/Ro and SS-B/La. Comparison with systemic lupus erythematosus and primary Sjogren's syndrome Br. J. Rheumatol. 34 1995 901 907
164. 1. Kälkner K.M. Rönnblom L. Karlsson Parra A.K. Bengtsson M. Olsson Y. Oberg K. Antibodies against double-stranded DNA and development of polymyositis during treatment with interferon Q. J. Med. 91 1998 393 399
165. 2. Karsh J. Halbert S.P. Anken M. Klima E. Steinberg A.D. Anti-DNA, antideoxyribonucleoprotein and rheumatoid factor measured by ELISA in patients with systemic lupus erythematosus, Sjogren's syndrome and rheumatoid arthritis Int. Arch. Allergy Appl. Immunol. 68 1982 60 69
166. 3. Kato N. Hiro O.H. Fumio H. Nucleotide sequence of 45S RNA (C8 or hY5) from HeLa cells Biochem. Biophys. Res. Commun. 108 1982 363 370
167. 4. Kato T. Sasakawa H. Suzuki S. Shirako M. Tashiro F. Autoepitopes of the 52-kd SS-A/Ro molecule Arthritis Rheum. 38 1995 990 998
168. 5. Klinman D.M. Eisenberg R.A. Steinberg A.D. Development of the autoimmune B cell repertoire in MRL-lpr/lpr mice J. Immunol. 144 1990 506 511
169. 6. Klinman D.M. Steinberg A.D. Systemic autoimmune disease arises from polyclonal B cell activation J. Exp. Med. 165 1987 1755 1760
170. 7. Koffler D. Schur P.H. Kunkel H.G. Immunological studies concerning the nephritis of systemic lupus erythematosus J. Exp. Med. 126 1967 607 624
171. 8. Korb L.C. Ahearn J.M. Cutting Edge: C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: Complement deficiency and systemic lupus erythematosus revisited J. Immunol. 158 1997 4525 4528
172. 9. Koren E. Koscec M. Wolfson-Reichlin M. Ebling F.M. Tsao B Murine and human antibodies to native DNA that cross-react with the A and D SnRNP polypeptides cause direct injury of cultured kidney cells J. Immunol. 154 1995 4857 4864
173. 10. Kozyr A.V. Sashchenko L.P. Kolesnikov A.V. Zelenova N.A. Khaidukov S.V. Anti-DNA autoantibodies reveal toxicity to tumor cell lines Immunol. Lett. 80 2002 41 47
174. 11. Kramers K. van Bruggen M.C. Rijke-Schilder T.P. Dijkman H.B. Hylkema M.N. In vivo ANA is a fixation artifact: Nucleosome-complexed antinucleosome autoantibodies bind to the cell surface and are internalized J. Am. Soc. Nephrol. 7 1996 946 954
175. 12. Krishnan M.R. Jou N.T. Marion T.N. Correlation between the amino acid position of arginine in VH-CDR3 and specificity for native DNA among autoimmune antibodies J. Immunol. 157 1996 2430 2439
176. 1. Laderach D. Bach J.F. Koutouzov S. Nucleosomes inhibit phagocytosis of apoptotic thymocytes by peritoneal macrophages from MRL+/+ lupus-prone mice J. Leukocyte Biol. 64 1998 774 780
177. 2. Lahita R. Special report: Adjusted lupus prevalence. Results of a marketing study by the Lupus Foundation of America Lupus 4 1996 450 453
178. 3. Lai K.N. Leung J.C. Lai K.B. Lai C.K. Effect of anti-DNA autoantibodies on the gene expression of interleukin 8, transforming growth factor-beta, and nitric oxide synthase in cultured endothelial cells Scand. J. Rheum. 26 1997 461 467
179. 4. Lai K.N. Leung J.C.K. Lai K.B. Wong K.C. Lai C.K.W. Upregulation of adhesion molecule expression on endothelial cells by anti-DNA autoantibodies in systemic lupus erythematosus Clin. Immunol. Immunopathol. 81 1996 229 238
180. 5. Lambert P.H. Dixon F.J. Pathogenesis of the glomerulonephritis in NZB/W mice J. Exp. Med. 127 1967 507 521
181. 6. Landry M. Phagocyte function and cell-mediated immunity in systemic lupus erythematosus Arch. Dermatol. 113 1997 147 154
182. 7. Lawrence S. Luy L. Laxer R. Krafchik B. Silverman E. The health of mothers of children with cutaneous neonatal lupus erythematosus differs from that of mothers of children with congenital heart block Am. J. Med. 108 2000 705 709
183. 8. Lazarus M. Hajeer A.H. Turner D. Sinnott D. Worthighton J. Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus J. Rheumatol. 24 1997 2314 2317
184. 9. Lee J.S. Latimer L.J. Woodsworth M.L. A monoclonal antibody specific for the duplex DNA poly[d(TC)]·poly[d(GA)] FEBS Lett. 190 1985 120 124
185. 10. Lee J.S. Woodsworth M.L. Latimer L.J. Monoclonal antibodies specific for poly(dG)×poly(dC) and poly(dG)× poly(dm5C) Biochemistry 23 1984 3277 3281
186. 11. Lee L.A. Neonatal lupus erythematosus J. Invest. Dermatol. 100 1993 9S 13S
187. 12. Lee L.A. Norris D.A. Weston W.L. Neonatal lupus and the pathogenesis of cutaneous lupus Pediatr. Dermatol. 3 1986 491 497
188. 13. Lee L.A. Weston W.L. Krueger G.G. Emam M. Reichlin M. An animal model of antibody binding in cutaneous lupus Arthritis Rheum. 29 1986 782 788
189. 14. Lefkowith J.B. Kiehl M. Rubenstein J. Divalerio R. Bernstein K. Heterogeneity and clinical significance of glomerular-binding antibodies in systemic lupus erythematosus J. Clin. Invest. 98 1996 1373 1380
190. 15. Lefkowith J.B. Gilkeson G.S. Nephritogenic autoantibodies in lupus Arthritis Rheum 39 1996 894 903
191. 16. Lehman T.J. A practical guide to systemic lupus erythematosus Pediatr. Clin. North Am. 42 1995 1223 1238
192. 17. Lehman P. Holzle E. Kind P. Goerz G. Plewig G. Experimental reproduction of skin lesions in lupus erythematosus by UVA and UVB radiation J. Am. Acad. Dermatol. 22 1990 181 187
193. 18. Li J.M. Horsfall A.C. Maini R.N. Anti-La (SS-B) but not anti-Ro52 (SS-A) antibodies cross-react with laminin—A role in the pathogenesis of congenital heart block? Clin. Exp. Immunol. 99 1995 316 324
194. 19. Lin C.Y. Sheng C.C. Lin C.C. Chen C.H. Chou P. Mass urinary screening and follow-up for school children in Taiwan Province Acta Paediatr. Taiwan. 42 2001 134 140
195. 20. Lindorfer M.A. Schuman T.A. Craig M.L. Martin E.N. Taylor R.P. A bispecific dsDNA x monoclonal antibody construct for clearance of anti-dsDNA IgG in systemic lupus erythematosus J. Immunol. Meth. 248 2001 125 138
196. 21. (Baltimore) Lloyd W. Schur P.H. Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE) Medicine 60 1981 208 217
197. 22. Lorenz H.-M. Grünke M. Hieronymus T. Herrmann M. Kühnel A. In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases Arthritis Rheum. 40 1997 306 317
198. 23. Losman M.J. Fasy T.M. Novick K.E. Monestier M. Relationships among antinuclear antibodies from autoimmune MRL mice reacting with histone H2A-H2B dimers and DNA Int. Immunol. 5 1993 513 523
199. 24. Ludivico C.L. Zweiman B. Myers A.R. Hebert J. Green P.A. Predictive value of anti-DNA antibody and selected laboratory studies in systemic lupus erythematosus J. Rheumatol. 7 1980 843 849
200. 1. Madaio M.P. The role of autoantibodies in the pathogenesis of lupus nephritis Semin. Nephrol. 19 1999 48 56
201. 2. Madaio M.P. Carlson J. Cataldo J. Ucci A. Migliorini P. Pankewycz O. Murine monoclonal anti-DNA atibodies bind directly to glomerular antigens and form immune deposits J. Immunol. 138 1987 2883 2889
202. 3. Madaio M.P. Hodder S. Schwartz R.S. Stollar B.D. Responsiveness of autoimmune and normal mice to nuclei acid antigens J. Immunol. 132 1984 872 876
203. 4. Maddison P.J. The neonatal lupus syndrome Clin. Exp. Rheumatol. 6 1988 169 172
204. 5. Maddison P.J. Reichlin M. Deposition of antibodies to a soluble cytoplasmic antigen in the kidneys of patients with systemic lupus erythematosus Arthritis Rheum. 22 1979 858 863
205. 6. Marion T.N. Krishnan M.R. Desai D.D. Jou N.T. Tillman D.M. Monoclonal anti-DNA antibodies: Structure, specificity, and biology Methods 11 1997 3 11
206. 7. Marion T.N. Tillman D.M. Jou N.T. Interclonal and intraclonal diversity among anti-DNA antibodies from an (NZB x NZW)F1 mouse J. Immunol. 145 1990 2322 2332
207. 8. Marrack P. Kappler J. Mitchell T. Type I interferons keep activated T cells alive J. Exp. Med. 189 1999 521 530
208. 9. Mathews M.B. Francoeur A.M. La antigen recognizes and binds to the 3′-oligouridylate tail of a small RNA Mol. Cell. Biol. 4 1984 1134 1140
209. 10. Matzinger P. Tolerance, danger, and the extended family Annu. Rev. Immunol. 12 1994 991 1045
210. 11. McCauliffe D.P. Neonatal lupus erythematosus: A transplacentally acquired autoimmune disorder Semin. Dermatol. 14 1995 47 53
211. 12. McCauliffe D.P. Yin H. Wang L.X. Lucas L. Autoimmune sera react with multiple epitopes on recombinant 52 and 60 kDa Ro(SSA) proteins J. Rheumatol. 21 1994 1073 1080
212. 13. McCuistion C.H. Schoch E.P. Possible discoid lupus erythematosus in a newborn infant Arch. Dermatol. 70 1954 782 785
213. 14. McCune A.B. Weston W.L. Lee L.A. Maternal and fetal outcome in neonatal lupus erythematosus Ann Int. Med. 106 1987 518 523
214. 15. Meilof J.F. Veldhoven C.H.A. Swaak A.J.G. Smeenk R.J.T. Production of anti-Ro/SS-A and anti-La/SS-B autoantibodies is closely coordinated in systemic lupus erythematosus and independent of anti-dsDNA production J. Autoimmun. 10 1997 67 75
215. 16. Mevorach D. Zhou J.L. Song X. Elkon K.B. Systemic exposure to irradiated apoptotic cells induces autoantibody production J. Exp. Med. 188 1998 387 392
216. 17. Millard T.P. McGregor J.M. Molecular genetics of cutaneous lupus erythematosus Clin. Exp. Permatol. 26 2001 184 191
217. 18. Miranda M.E. Tseng C.E. Rashbaum W. Ochs R.L. Casiano C.A. Accessibility of SSA/Ro and SSB/La antigens to maternal autoantibodies in apoptotic human fetal cardiac myocytes J. Immunol. 161 1998 5061 5069
218. 19. Miranda-Carus M.E. Boutjdir M. Tseng C.E. DiDonato F. Chan E.K. Buyon J.P. Induction of antibodies reactive with SSA/Ro-SSB/La and development of congenital heart block in a murine model J. Immunol. 161 1998 5886 5892
219. 20. Mol C.D. Muir A.K. Lee J.S. Anderson W.F. Structure of an immunoglobulin Fab fragment specific for poly(dG)·poly(dC). J. Biol. Chem. 269 1994 3605 3614
220. 21. Morley K.D. Bernstein R.M. Bunn C.C. Gharavi A.E. Fortin M.T. Thrombocytopenia and anti-Ro Lancet 2 8252 1981 940
221. 22. Morquio L. Sur une maladie infantile et familiale caracterisee et la aort subite Arch. Med. Enfants 6 1901 467 470
222. 23. Moser K.L. Neas B.R. Salmon J.E. Yu H. Gray-McGuire C. Genome scan of human systemic lupus erythematosus: Evidence for linkage on chromosome 1q in African-American pedigrees Proc. Natl. Acad. Sci. USA 95 1998 14869 14874
223. 24. Munns T.W. Liszewski M.K. Hahn B.H. Antibody-nucleic acid complexes. Conformational and base associated with spontaneously occurring poly- and monoclonal anti-DNA antibodies from autoimmune mice Biochemistry 23 1984 2964 2970
224. 1. Nagata S. Suda T. Fas and Fas ligand: 1pr and gld mutations Immunol. Today 16 1995 39 43
225. 2. Natali P.G. Tan E.M. Experimental skin lesions in mice resebling systemic lupus erythematosus Arthritis Rheum. 16 1973 579 589
226. 3. Nemazee D.A. Bürki K. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes Nature 337 1989 562 566
227. 4. Nezlin R. Alarcón-Segovia D. Shoenfeld Y. Immunochemical determination of DNA in immune complexes present in the circulation of patients with systemic lupus erythematosus J. Autoimmun. 11 1998 489 493
228. 5. Nossent J.C. Henzen-Logman S.C. Vroom T.M. Huysen V. Berden J.H. Swaak A.J. Relation between serological data at the time of biopsy and renal histology in lupus nephritis Rheumatol. Int. 11 1991 77 82
229. 1. O'Brien C.A. Harley J.B. A subset of Y RNAs are associated with erythrocyte Ro ribonucleoproteins EMBO J. 9 1990 3683 3689
230. 2. O'Brien C.A. Wolin S.L. A possible role for the 60-kD Ro autoantigen in a discard pathway for defective 5S rRNA precursors Genes Dev. 8 1994 2891 2903
231. 3. Ofosu-Appiah W. Sfeir G. Viti D. Burashnikova E. Suppression of systemic lupus erythematosus disease in mice by oral administration of kidney extract J. Autoimmun. 13 1999 405 414
232. 4. Ohashi P.S. Oehen S. Buerki K. Pircher H. Ohashi C.T. Ablation of “tolerance” and induction of diabetes by virus infection in viral antigen transgenic mice Cell 65 1991 305 317
233. 5. Ohnishi K. Ebling F.M. Mitchell B. Singh R.R. Hahn B.H. Tsao B.P. Comparison of pathogenic and non-pathogenic murine antitodies to DNA: Antigen binding and structural characteristics Int. Immunol. 6 1994 817 830
234. 6. Okudaira K. Yoshizawa H. Williams R.C. Jr. Monoclonal murine anti-DNA antibody interacts with living mononuclear cells Arthritis Rheum. 30 1987 669 678
235. 1. Papoian R. Pillarisetty R. Talal N. Immunological regulation of spontaneous antibodies to DNA and RNA. II. Sequential switch from IgM to IgG in NZB/NZW F1 mice Immunol. 32 1977 75 79
236. 2. Perez V.L. Van Parijs L. Biuckians A. Zheng X.X. Strom T.B. Abas A.K. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement Immunity 6 1997 411 417
237. 3. Pisetsky D.S. Grudier J.P. Polyspecific binding of Escherichia coli beta-galactosidase by murine antibodies to DNA J. Immunol. 143 1989 3609 3613
238. 4. Plotz P.H. Autoantibodies are anti-idiotype antibodies to antiviral antibodies Lancet 2 8354 1983 824 826
239. 5. Press J. Uziel Y. Laxer R.M. Luy L. Hamilton R.M. Silverman E.D. Long-term outcome of mothers of children with complete congential heart block Am. J. Med. 100 1996 328 332
240. 6. Provost T.T. Amett F.C. Reithlin M. Homozygous C2 deficiency, lupus erythematosus and anti-Ro(SS-A) antibodies Arthritis Rheum. 26 1983 1279 1282
241. 7. Provost T.T. Watson R. Gammon W.R. Radowsky M. Harley J.B. Reichlin M. The neonatal lupus syndrome associated with U1RNP (nRNP) antibodies N. Eng. J. Med. 316 1987 1135 1138
242. 8. Provost T.T. Watson R. Simmons-O'Brien E. Significance of anti-Ro (SS-A) antibody in evaluation of patients with cutaneous manifestations of a connective tissue disease J. Am. Acad. Dermatol. 35 1996 147 169
243. 9. Pulendran B. Kannourakis G. Nouri S. Smith K.G. Nossal G.J. Soluble antigen can cause enhanced apoptosis of germinal-centre B cells Nature 375 1995 331 334
244. 1. Query C.C. Keene J.D. A human autoimmune protein associated with U1 RNA contains a region of homology that is cross-reactive with retroviral p30gag antigen Cell 51 1987 211 220
245. 1. Radic M.Z. Mackle J. Erikson J. Mol C. Anderson W.F. Weigert M. Residues that mediate DNA binding of autoimmune antibodies J. Immunol. 150 1993 4966 4977
246. 2. Raptis L. Menard H.A. Quantitation and characterization of plasma DNA in normals and patients with systemic lupus erythematosus J. Clin. Invest. 66 1980 1391 1399
247. 3. Raz E. Ben-Bassat H. Davidi T. Shlomai Z. Eilat D. Cross-reactions of anti-DNA autoantibodies with cell surface proteins Eur. J. Immunol. 23 1993 383 390
248. 4. Raz E. Brezis M. Rosenman E. Eilat D. Anti-DNA antibodies bind directly to renal antigens and induce kidney dysfunction in the isolated perfused rat kidney J. Immunol. 142 1989 3076 3082
249. 5. Reed B.R. Lee L.A. Harmon C. Wolfe R. Wiggins J. Autoantibodies to SS-A/Ro in infants with congenital heart block J. Pediatr. 103 1983 889 891
250. 6. Reichlin M. Cellular dysfunction induced by penetration of autoantibodies into living cells: Cellular damage and dysfunction mediated by antibodies to dsDNA and ribosomal P proteins J. Autoimmun. 11 1998 557 561
251. 7. Reichlin M. Brucato A. Frank M.B. Maddison P.J. McCubbin V.R. Concentration of autoantibodies to native 60-kd Ro/SS-A and denatured 52-kd Ro/SS-A in eluates from the heart of a child who died with congenital complete heart block Arthritis Rheum 37 1994 1698 1703
252. 8. Rekvig O.P. Hannestad K. The specificity of human autoantibodies that react with both cell nuclei and plasma membranes: The nuclear antigen is present on core mononucleosomes J. Immunol. 123 1979 2673 2681
253. 9. Ricchiuti V. Briand J.P. Meyer O. Isenberg D.A. Pruijn G. Muller S. Epitope mapping with synthetic peptides of 52-kD SSA/Ro protein reveals heterogeneous antibody profiles in human autoimmune sera Clin. Exp. Immunol. 95 1994 397 407
254. 10. Riley R.L. McGrath H. Jr. Taylor R.P. Detection of low avidity anti-DNA antibodies in systemic lupus erythematosus Arthritis Rheum. 22 1979 219 225
255. 11. Robbins W.C. Holman H.R. Deicher H. Kunkel H.G. Complement fixation with cell nuclei and DNA in lupus erythematosus Proc. Soc. Exp. Biol. Med. 96 1957 575 579
256. 12. Rönnblom L.E. Alm G.V. An epiopathogenic role for the type I IFN system in SLE Trends Immunol. 22 2001 427 431
257. 13. Rönnblom L.E. Alm G.V. Oberg K.E. Possible induction of systemic lupus erythematosus by interferon-alpha treatment in a patient with a malignant carcinoid tumour J. Intern. Med. 27 1990 207 210
258. 14. Rönnblom L.E. Alm G.V. Oberg K.E. Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors Ann. Intern. Med. 115 1991 178 183
259. 15. Rosen A. Casciola-Rosen L. Ahearn J. Novel packages of viral and self-antigens are generated during apoptosis J. Exp. Med. 181 1995 1557 1561
260. 16. Rothfield N.F. Stollar B.D. The relation of immunoglobulin class, pattern of anti-nuclear antibody, and complement-fixing antibodies to DNA in sera from patients with systemic lupus erythematosus J. Clin. Invest. 46 1967 1785 1794
261. 17. Rovere P. Vallinoto C. Bondanza A. Crosti M.C. Rescigno Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function J. Immunol. 161 1998 4467 4471
262. 18. Rubin R.L. Carr R.I. Anti-DNA activity of IgG F(ab′) from normal human serum J. Immunol. 122 1979 1604 1607
263. 19. Rubin R.L. Nusinow S.R. Johnson A.D. Rubenson D.S. Curd J.G. Tan E.M. Serologic change during induction of lupus-like disease by procainamide Am. J. Med. 80 1986 999 1002
264. 20. Rubin R.L. Waga S. Antihistone antibodies in systemic lupus erythematosus J. Rheumatol. 14 Suppl. 13 1987 118 126
265. 21. Rumore P.M. Steinman C.R. Endogenous circulating DNA in systemic lupus erythematosus: Occurrence as multimeric complexes bound to histone J. Clin. Invest. 86 1990 69 74
266. 1. Santini S.M. Lapenta C. Logozzi M. Parlato S. Spada M. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice J. Exp. Med. 191 2000 1777 1788
267. 2. Savill J. Fadok V. Henson P. Haslett C. Phagocyte recognition of cells undergoing apoptosis Immunol. Today 14 1993 131 136
268. 3. Schmiedeke T.M. Stockl F.W. Weber R. Sugisaki Y. Batsford S.R. Vogt A. Histones have high affinity for the glomerular basement membrane. Relevance for immune complex formation in lupus nephritis J. Exp. Med. 169 1989 1879 1894
269. 4. Schwartz R.H. A cell culture model for T lymphocyte clonal anergy Science 248 1990 1349 1356
270. 5. Schwartz R.S. Stollar B.D. Origins of anti-DNA antibodies J. Clin. Invest. 75 1985 321 327
271. 6. Scofield R.H. Farris A.D. Horsfall A.C. Harley J.B. Fine specificity of the autoimmune response to the Ro/SSA and La/SSB ribonucleoproteinss Arthritis Rheum. 42 1999 199 209
272. 7. Scopelitis E. Biundo J.J. Jr. Alspaugh M.A. Anti-SS-A antibody and other antinuclear antibodies in systemic lupus erythematosus Arthritis Rheum. 23 1980 287 293
273. 8. Scott J.S. Maddison P.J. Taylor P.V. Esscher E. Scott O. Skinner R.P. Connective-tissue disease, antibodies to ribonucleoprotein, and congenital heart block N. Engl. J. Med. 309 1983 209 212
274. 9. Schur P.H. Genetics of systemic lupus erythematosus Lupus 4 1995 425 437
275. 10. Sharma A. Isenberg D.A. Diamond B. Crossreactivity of human anti-dsDNA antibodies to phosphorylcholine: Clues to their origin J. Autoimmun. 16 2001 479 484
276. 11. Shoenfeld Y. Zamir R. Joshua H. Lavie G. Pinkhas J. Human monoclonal anti-DNA antibodies react as lymphocytotoxic antibodies Eur. J. Immunol. 15 1985 1024 1028
277. 12. Shokat K.M. Goodnow C.C. Antigen-induced B-cell death and elimination during germinal-centre immune responses Nature 375 1995 334 338
278. 13. Shuster A.M. Gololobov G.V. Kvashuk O.A. Bogomolova A.E. Smirnov I.V. Gabibov A.G. DNA hydrolyzing autoantibodies Science 256 1992 665 667
279. 14. Siegert C. Daha M. Westedt M.L. van der Voort E. Breedveld F. IgG autoantibodies against C1q are correlated with nephritis, hypocomplementemia, and dsDNA antibodies in systemic lupus erythematosus J. Rheum. 18 1991 230 234
280. 15. Silverman E.D. Buyon J. Laxer R.M. Hamilton R. Bini P. Autoantibody response to the Ro/La particle may predict outcome in neonatal lupus erythematosus Clin. Exp. Immunol. 100 1995 499 505
281. 16. Silverman E.D. Laxer R.M. Neonatal lupus erythematosus Rheum. Dis. Clin. North Am. 23 1997 599 618
282. 17. Sinigaglia F. D'Ambrosio D. Rogge L. Type I interferons and the Th1/Th2 paradigm Dev. Comp. Immunol. 23 1999 657 663
283. 18. Skinner R.P. Maddison P.J. Analysis of polyethylene glycol precipitates from SLE sera: Antibody enrichment in association with disease activity Clin. Exp. Rheum. 8 1990 553 560
284. 19. Slingsby J.H. Norsworthy P. Pearce G. Vaishnaw A.K. Issler H. Homozygous hereditary C1q deficiency and systemic lupus erythematosus Arthritis Rheum. 39 1996 663 670
285. 20. Smeenk R.J. van den Brink H.G. Brinkman K. Termaat R.M. Berden J.H. Swaak A.J. Anti-dsDNA: Choice of assay in relation to clinical value Rheumatol. Int. 11 1991 101 107
286. 21. Smeenk R. van der Lelij G. Aarden L. Avidity of antibodies to dsDNA: Comparison of IFT on Crithidia luciliae , FARR assay and PEG assay J. Immunol. 128 1982 73 78
287. 22. Smeenk R.J.T. Van Rooijen A. Swaak T.J.G. Dissociation studies of DNA/anti-DNA complexes in relation to anti-DNA avidity J. Immunol. Meth. 109 1988 27 35
288. 23. Smeenk R. Westgeest T. Swaak T. Antinuclear antibody determination: The present state of diagnostic and clinical relevance Scand. J. Rheumatol. Suppl. 56 1985 78 92
289. 24. Smith C.D. Cyr M. The history of lupus erythematosus from Hippocrates to Osler Rheum. Dis. Clin. North. Am. 14 1988 1 19
290. 25. Song Y.W. Han C.-W. Kang S.-W. Baek H.-J. Lee E.-B. Abnormal distribution of the Fcγ receptor type IIa polymorphisms in Korean patients with systemic lupus erythematosus Arthritis Rheum. 41 1998 412 426
291. 26. Stefano J.E. Purified lupus antigen La recognizes an oligouridylate stretch common to the 3′ termini of RNA polymerase III transcripts Cell 36 1984 145 154
292. 27. Steinman C.R. Circulating DNA in systemic lupus erythematosus: Association with central nervous system involvement and systemic vasculitis Am. J. Med. 67 1979 429 435
293. 28. Steward M.W. Hay F.C. Changes in immunoglobulin class and subclass of anti-DNA antibodies with increasing age in NZB/WF1 hybrid mice Clin. Exp. Immunol. 26 1976 363 370
294. 29. Sun Y. Fong K.-Y. Chung M.C.M. Yao Z.-J. Peptide mimicking antigenic and immunogenic epitope of double-stranded DNA in systemic lupus erythematosus Int. Immunol. 13 2001 223 232
295. 30. Sun K.H. Liu W.T. Tsai C.Y. Tang S.J. Han S.H. Yu C.L. Anti-dsDNA antibodies cross-react with ribosomal P proteins expressed on the surface of glomerular mesangial cells to exert a cytostatic effect Immunology 85 1995 262 269
296. 31. Sun K.H. Liu W.T. Tang S.J. Tsai C.Y. Hsieh S.C. The expression of acidic ribosomal phosphoproteins on the surface membrane of different tissues in autoimmune and normal mice which are the target molecules for anti-double-stranded DNA antibodies Immunology 87 1996 362 371
297. 32. Sun K.H. Yu C.L. Tang S.J. Sun G.H. Monoclonal anti-double-stranded DNA autoantibody stimulates the expression and release of IL-1 β, IL-6, IL-8, IL-10 and TNF-α from normal human mononuclear cells involving in the lupus pathogenesis Immunology 99 2000 352 360
298. 33. Suenaga R. Abdou N.I. Anti-(DNA-histone) antibodies in active lupus nephritis J. Rheum. 23 1996 279 284
299. 34. Svensson B.O. Serum factors causing impaired macrophage function in systemic lupus erythematosus Scand. J. Immunol. 4 1975 145 150
300. 35. Suzuki K. The role of immunoadsorption using dextran-sulfate cellulose columns in the treatment of systemic lupus erythematosus Ther. Apheresis 4 2000 239 243
301. 36. Swaak A.J. Aarden L.A. Statius van Eps L.W. Feltkamp T.E. Anti-dsDNA and complement profiles as prognostic guides in systemic lupus erythematosus Arthritis Rheum. 22 1979 226 235
302. 37. Swaak A.J. Groenwold J. Aarden L.A. Statius van Eps L.W. Feltkamp E.W. Prognostic value of anti-dsDNA in SLE Ann. Rheum. Dis. 41 1982 388 395
303. 38. Swaak T. Smeenk R. Detection of anti-dsDNA as a diagnostic tool: A prospective study in 441 non-systemic lupus erythematosus patients with anti-dsDNA antibody (anti-dsDNA) Ann. Rheum. Dis. 44 1985 245 251
304. 39. Synkowski D.R. Reichlin M. Provost T.T. Serum antibodies in systemic lupus erythematosus and correlation with cutaneous features J. Rheumatol. 9 1982 380 385
305. 1. Tan E.M. Cohen A.S. Fries J.F. Masi A.T. McShane D.J. The 1982 Revised Criteria for the classification of systemic lupus erythematosus Arthritis Rheum. 25 1982 1271 1277
306. 2. Tax W.J.M. Kramers C. Vanbruggen M.C.J. Berden J.H.M. Apoptosis, nucleosomes, and nephritis in systemic lupus erythematosus Kidney Int. 48 1995 666 673
307. 3. ter Borg E.J. Horst G. Hummel E.J. Limburg P.C. Kallenberg C.G. Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus Arthritis Rheum. 33 1990 634 643
308. 4. Thornton C.M. Eichenfield L.F. Shinall E.A. Siegfried E. Rabinowitz L.G. Cutaneous telangiectases in neonatal lupus erythematosus J. Am. Acad. Dermatol. 33 1995 19 25
309. 5. Tiegs S.L. Russell D.M. Nemazee D. Receptor editing in self-reactive bone marrow B cells J. Exp. Med. 177 1993 1009 1020
310. 6. Tomasz M. Barton J.K. Magliozzo C.C. Tucker D. Lafer E.M. Stollar B.D. Lack of Z-DNA conformation in mitomycin-modified polynucleotides having inverted circular dichroism Proc. Natl. Acad. Sci. USA 80 1983 2874 2878
311. 7. Tron F. Letarte J. Roque-Anunes Barreira M.C. Lesarve P. Specific detection of circulating DNA:anti-DNA immune complexes in human systemic lupus erythematosus sera using murine monoclonal anti-DNA antibody Clin. Exp. Immunol. 49 1982 481 487
312. 8. Truner D.M. Williams D.M. Sanakaran D. Lazarus M. Sinnott P.J. Hutchinsin I.V. An investigation of the polymorphisms in the interleukin-10 gene promoter Eur. J. Immunogenet. 24 1997 1 8
313. 9. Tsai C.Y. Wu T.H. Sun K.H. Liao T.S. Lin W.M. Yu C.L. Polyclonal IgG anti-dsDNA antibodies exert cytotoxic effect on cultured rat mesangial cells by binding to cell membrane and augmenting apoptosis Scand. J. Rheum. 22 1993 162 171
314. 10. Tsao B.P. Cantor R.M. Kalunian K.C. Chen C.-J. Badsha H. Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus J. Clin. Invest. 99 1997 725 731
315. 1. Uramoto K.M. Michet C.J. Thumboo J. Sunku J. O'Fallon W.M. Trends in the incidence and mortality of systemic lupus erythematosus, 1950–1992 Arthritis Rheum. 42 1999 46 50
316. 2. Utz P.J. Hottelet M. van Venrooij W.J. Anderson P. Association of phosphorylated serine/arginine (SR) splicing factors with the U1-small ribonucleoprotein (snRNP) autoantigen complex accompanies apoptotic cell death J. Exp. Med. 187 1998 547 560
317. 1. Vallin H. Blömberg S. Alm G.V. Cederblad B. Rönnblom L. Patients with systemic lupus erythematosus (SLE) have a circulating inducer of interferon-alpha (IFN-alpha) production acting on leucocytes resembling immature dendritic cells Clin. Exp. Immunol. 115 1999 196 202
318. 2. Vallin H. Perers A. Alm G.V. Rönnblom L. Anti-double-stranded DNA antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN-alpha inducer in systemic lupus erythematosus J. Immunol. 163 1999 6306 6313
319. 3. van Es J.H. Gmelig Meyling F.H. van de Akker W.R. Aanstoot H. Derksen R.H. Logtenberg T. Somatic mutations in the variable regions of a human IgG anti-double-stranded DNA autoantibody suggest a role for antigen in the induction of systemic lupus erythematosus J. Exp. Med. 173 1991 461 470
320. 4. Van Houten N. Budd R.C. Accelerated programmed cell death of MRL-lpr/lpr T lymphocytes J. Immunol. 149 1992 2513 2517
321. 5. Van Parijs I. Abbas A.K. Role of Fas-mediated cell death in the regulation of immune responses Curr. Opin. Immunol. 8 1996 355 361
322. 6. Van Parijs L. Abbas A.K. Homeostasis and self-tolerance in the immune system: Turning lymphocytes off Science 280 1998 243 248
323. 7. Vazquez Doval J. Sanchez Ibarrola A. Defective mononuclear phagocyte function in systemic lupus erythematosus: Relationship of FcRII (CD32) with intermediate cytoskeletal filaments J. Inv. Allergol. Clin. Immunol. 3 1993 86 91
324. 8. Vlahakos D. Foster M.H. Ucci A.A. Barrett K.J. Datta S.K. Madaio M.P. Murine monoclonal anti-DNA antibodies penetrate cells, bind to nuclei, and induce glomerular proliferation and proteinuria in vivo J. Am. Soc. Nephrol. 2 1992 1345 1354
325. 9. Vlahakos D.V. Foster M.H. Adams S. Katz M. Ucci A.A. Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites Kidney Int. 41 1992 1690 1700
326. 10. Voll R.E. Herrmann M. Roth E.A. Stach C. Kalden J.R. Girkontaite I. Immuno-suppressive effects of apoptotic cells Nature 390 1997 350 351
327. 1. Wallace D.J. Goldfinger D. Pepkowitz S.H. Fichman M. Metzger A.L. Schroeder J.O. Randomized controlled trial of pulse/synchronization cyclophosphamide/apheresis for proliferative lupus nephritis J. Clin. Apheresis 13 1998 163 166
328. 2. Walport M.J. Complement deficiency and disease Br. J. Rheumatol. 32 1993 269 273
329. 3. Walport M.J. Davies K.A. Botto M. C1q and systemic lupus erythematosus Immunobiology 199 1998 265 285
330. 4. Walport M.J. Davies K.A. Morley B.J. Botto M. Complement deficiency and autoimmunity Ann. N. Y. Acad. Sci. 815 1997 267 281
331. 5. Wasicek C.A. Reichlin M. Clinical and serological differences between systemic lupus erythematosus patients with antibodies to Ro versus patients with antibodies to Ro and La J. Clin. Invest. 69 1982 835 843
332. 6. Watson R. Kang J.E. May M. Hudak M. Kickler T. Provost T.T. Thrombocytopenia in the neonatal lupus syndrome Arch. Dermatol. 124 1988 560 563
333. 7. Watson R.M. Lane A.T. Barnett N.K. Bias W.B. Arnett F.C. Provost T.T. Neonatal lupus erythemaosus: A clinical, serological and immunogenetic study with review of the literature Medicine 63 1984 362 378
334. 8. Weinstein A. Drug-induced systemic lupus erythematosus Prog. Clin. Immunol. 4 1980 1 21
335. 9. Weinstein A. Bordwell B. Stone B. Tibbetts C. Rothfield N.F. Antibodies to native DNA and serum complement (C3) levels. Application to diagnosis and classification of systemic lupus erythematosus Am. J. Med. 74 1983 206 216
336. 10. Werle E. Blazek M. Fiehn W. The clinical significance of measuring different anti-dsDNA antibodies by using the Farr assay, an enzyme immunoassay and a Chrithidia luciliae immunofluorescence test Lupus 1 1992 369 377
337. 11. Winkler T.H. Fehr H. Kalden J.R. Analysis of immunoglobulin variable region genes from human IgG anti-DNA hybridomas Eur. J. Immunol. 22 1992 1719 1728
338. 12. Wolach B. Choc L. Pomeranz A. Ben Ari Y. Douer D. Metzker A. Aplastic anemia in neonatal lupus Am. J. Dis. Child. 147 1993 941 944
339. 13. Wold R.T. Young F.E. Tan E.M. Farr R.S. Deoxyribonucleic acid antibody: A method to detect its primary interaction with deoxyribonucleic acid Science 161 1968 806 807
340. 14. Wolin S.L. Steitz J.A. The Ro small cytoplasmic ribonucleoproteins: Identification of the antigenic protein and its binding site on the Ro RNAs Proc. Natl. Acad. Sci. USA 81 1984 1996 2000
341. 15. Wu J. Edberg J.C. Redcha P.B. Bansal V. Guyre P.M. A novel polymorphism of FcγRIIIa (CD16) alters receptor function and predisposes to autoimmune disease J. Clin. Invest. 100 1997 1059 1070
342. 16. Wu J. Wilson J. He J. Xiang L. Schur P.H. Mountz J.D. Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease J. Clin. Invest. 98 1996 1107 1113
343. 17. Wyllie A.H. Kerr J.F. Currie A.R. Cell death: The significance of apoptosis Int. Rev. Cytol. 68 1980 251 306
344. 1. Yamagata H. harley J.B. Reichlin M. Molecular properties of the Ro/SS-A antigen and enzyme-linked immunosorbent assay for quantitation of antibody J. Clin. Invest. 74 1984 625 633
345. 2. Yanase K. Smith R.M. Puccetti A. Jarett L. Madaio M.P. Receptor-mediated cellular entry of nuclear localizing anti-DNA antibodies via myosin 1 J. Clin. Invest. 100 1997 25 31
346. 3. Yang L.Y. Chen A. Kuo Y.C. Lin C.Y. Efficacy of a pure compound H1-A extracted from Cordyceps sinensis on autoimmune disease of MRL lpr/lpr mice J. Lab. Clin. Med. 134 1999 492 500
347. 4. Yang L.Y. Chen W.P. Lin C.Y. Lupus nephritis in children. A review of 167 patients Pediatrics 94 1994 335 340
348. 1×NZW backcross mice J. Immunol. 127 1981 433 437
349. 6. Young-Sun Y. Edward K.W. The genetics of lupus Curr. Opin. Nephrol. Hypertens. 10 2001 437 443
350. 7. Ytterberg S.R. Schnitzer T.J. Serum interferon levels in patients with systemic lupus erythematosus Arthritis Rheum. 25 1982 401 406
351. 1. Zack D.J. Stempniak M. Wong A.L. Taylor C. Weisbart R.H. Mechanisms of cellular penetration and nuclear localization of an anti-double strand DNA autoantibody J. Immunol. 157 1996 2082 2088
352. 2. Zack D.J. Yamamoto K. Wong A.L. Stempniak M. French C. Weisbart R.H. DNA mimics a self-protein that may be a target for some anti-DNA antibodies in systemic lupus erythematosus J. Immunol. 154 1995 1987 1994
353. 3. Zimmermann C. Smolen J.S. Graninger W. Petera P. Fabini G. Fine specificity of anti-Ro(SSA) autoantibodies and clinical manifestations in patients with systemic lupus erythematosus J. Rheumatol. 23 1995 1897 1903